The next-generation sequencing market valued at US$ 13.92 billion in 2023, is forecasted to grow at a robust CAGR of 11.0%, ...

In this article, Cerba dives into CAR+ T-cell therapy, from patient treatment to solutions for minimal residual disease (MRD) ...

Discover the top genomics startups revolutionizing genome sequencing technologies to enhance disease prevention and treatment ...

Authenticated data presented in the Life science tools market report is based on findings of extensive primary and secondary research.

Datar Cancer Genetics (DCG) has launched Exacta AI, a next generation multi-analyte AI-driven platform providing optimized treatment options for cancer patients who have exhausted the standard options ...

Now in the market for the first time, the single-flow-cell NovaSeq X Sequencing System ... Geneviève DonPierre, team leader of NGS Sequencing at Génome Québec, stated, "The increased yield ...

Learn more about whether Qiagen N.V. or Repligen Corporation is a better investment based on AAII's A+ Investor grades, which ...

The company’s single-flow-cell NovaSeq X Sequencing ... to customers with broad compatibility across the NGS platform portfolio. The single-cell sample prep technology removes many of the ...